Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the effect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective study was made in children aged <5 years diagno...

Full description

Bibliographic Details
Main Authors: Sergi Hernández, Encarna Navas, Ignacio Aznar-Lou, Pilar Ciruela, Juan José García-García, Fernando Moraga-Llop, Carmen Muñoz-Almagro, Gemma Codina, Mariona F. de Sevilla, Sebastià González-Peris, Cristina Esteva, Ana María Planes, Conchita Izquierdo, Johanna Martínez-Osorio, Magda Campins, Sonia Uriona, Luis Salleras, Antoni Serrano-Blanco, Mireia Jané, Ángela Domínguez
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Vaccines
Subjects:
PCV7
PCV13
invasive pneumococcal disease
direct cost
Online Access:https://www.mdpi.com/2076-393X/8/3/387

Internet

https://www.mdpi.com/2076-393X/8/3/387

Similar Items